Pain Therapeutics, Durect fall on Remoxy review

by admin on May 10, 2013

Shares of Pain Therapeutics Inc. and Durect Corp. tumbled Friday after their partner Pfizer Inc. said it may not pursue further development of Remoxy, an experimental pain drug that has been plagued with …

View full post on pain – Yahoo! News Search Results

Previous post:

Next post: